The emerging treatment of the medication represents a major development in the care of type 2 diabetes. Distinct from existing therapies, tirzepatide impacts two pathways – the GLP-1 hormone and GIP – leading to https://tirzepatidepeptide774360.develop-blog.com/49945757/tirzepatide-peptide-a-new-frontier-in-diabetes-treatment